DEFA14A: TherapeuticsMD, Inc. to Hold Annual Stockholders Meeting on December 5, 2024
Proxy Statement
TherapeuticsMD, Inc. will hold its annual meeting of stockholders on December 5, 2024, to elect directors, approve executive compensation, and ratify the appointment of an independent auditor.
Summary
- TherapeuticsMD, Inc. is holding its annual meeting of stockholders on Thursday, December 5, 2024, at 8:00 AM Eastern Time.
- The meeting will be held live via the internet at www.proxydocs.com/TXMD.
- Stockholders of record as of October 17, 2024, are eligible to vote.
- The agenda includes the election of four directors: Tommy G. Thompson, Cooper C. Collins, Gail K. Naughton, Ph.D., and Justin Roberts.
- Stockholders will also vote on a non-binding advisory resolution regarding the compensation of named executive officers for the fiscal year ended December 31, 2023.
- The appointment of Berkowitz Pollack Brant Advisors + CPAs, LLP as the independent auditor for the fiscal year ending December 31, 2024, will be ratified.
- The Board of Directors recommends voting FOR all proposals.
Sentiment
Score: 5
Explanation: The document is a standard proxy statement, indicating a neutral sentiment.
Positives
- The meeting provides an opportunity for stockholders to participate in key decisions regarding the company's governance.
- The Board of Directors is providing clear recommendations on how to vote on each proposal.
Future Outlook
The document outlines the standard agenda items for an annual meeting, focusing on governance and compliance matters.
Industry Context
This is a standard corporate governance procedure for publicly traded companies, ensuring shareholder participation in key decisions.
Stakeholder Impact
- Shareholders have the opportunity to vote on key company matters.
- The outcome of the votes will influence the company's direction and governance.
Next Steps
- Stockholders should review the proxy materials and vote on the proposals.
- Attend the annual meeting on December 5, 2024, if desired.
Key Dates
| Date | Description |
|---|---|
| October 17, 2024 | Stockholders of record date for the annual meeting. |
| November 25, 2024 | Deadline to request a paper package of proxy materials in time for the meeting. |
| December 5, 2024 | Date of the Annual Meeting of Stockholders. |
| December 31, 2023 | Fiscal year end for executive compensation vote. |
| December 31, 2024 | Fiscal year end for independent auditor ratification. |
Keywords
Annual Meeting, Stockholders, Proxy Statement, Directors, Executive Compensation, Independent Auditor, TherapeuticsMD
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.